Orthofix Names Stephanie Walsh Chief Human Resources Officer

Published on July 16, 2024

LEWISVILLE, Texas, July 16, 2024–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the appointment of Stephanie Walsh as Chief Human Resources Officer. A seasoned human resources executive, Walsh joins Orthofix from ResMed Inc., a San Diego-based medical device company, where she served most recently as Vice President of Transformation. …

The post Orthofix Names Stephanie Walsh Chief Human Resources Officer appeared first on Ortho Spine News.

Continue reading on website
Other news

Paradigm BioDevices Launches VisiCORE ™ – The Clear Choice in Bone Graft Harvesting

July 16, 2024
CHARLESTON, S.C., July 16, 2024–(BUSINESS WIRE)–Paradigm BioDevices, Inc. announces the launch of VisiCORE, a new bone graft harvesting system for foot and ankle fusion surgeries designed with a clear collection tube with proprietary Graft Retention Technology (GRT)™. The system permits users to see bone graft harvests in real-time, minimizes bone graft loss during collection, reduces …The post Pa

DiscGenics Announces US FDA Approval to Proceed with Phase III Clinical Evaluation of Allogeneic, Injectable Disc Progenitor Cell Therapy for Symptomatic Lumbar Degenerative Disc Disease

July 16, 2024
Receives FDA acceptance on Phase III clinical protocols for parallel pivotal and confirmatory trials Achieves alignment with FDA on Chemistry, Manufacturing, and Controls (CMC) aspects of Phase III program SALT LAKE CITY, July 16, 2024 /PRNewswire/ — DiscGenics, Inc., a privately held, late-stage clinical, biopharmaceutical company developing allogeneic, cell-based, regenerative therapies for musc